Anxiety and Depression in Psychiatric Patients and Mental Health Professionals During the COVID-19 pandemic (Depression and Anxiety in COVID-19 pandemic)

Study identification

• EU PAS number:
  EUPAS34668
• Study ID:
  41871
• Official title and acronym:
  Anxiety and Depression in Psychiatric Patients and Mental Health Professionals During the COVID-19 pandemic (Depression and Anxiety in COVID-19 pandemic)
• DARWIN EU® study:
  No
• Study countries:
  Greece
• Study description:
  We examine the effects of the containment measures against the coronavirus 2019 disease (COVID-19) pandemic on anxiety and depression in patients and mental health professionals. We will conduct a prospective study in which 130 patients with mental health disorders and 60 mental health professionals will be assessed at three consecutive time-points (April, June and September 2020) at the Psychiatric Hospital of Attica (PHA) in Athens, Greece. All participants will be administered the Beck Depression (BDI) and the Beck Anxiety Inventory (BAI) and a demographic and clinical questionnaire. The participants will belong to two groups: a) one group of patients hospitalized in the PHA or accommodated in community units for people with mental health problems (hostels, boarding houses or supported apartments) and b) one group of mental health staff caring for the above patients. The primary outcomes will be the investigation of the time X group interactions on the BDI and BAI scores. We hypothesize that there will be a different effect of time on the BDI and BAI scores for the two groups and that the mental health professionals would be more sensitive to the effects of the containment measures on these scores. Secondary measures will be the effects of demographic and clinical variables on BDI and BAI total and item scores.
• Study status:
  Finalised

Research institutions and networks

Institutions

Psychiatric Hospital of Attica

Study timelines

Date when funding contract was signed

Planned:03/04/2020

Actual:03/04/2020

Study start date

Planned:06/04/2020

Actual:06/04/2020

Data analysis start date

Planned:01/12/2020

Date of interim report, if expected

Planned:01/02/2021

Date of final study report

Planned:01/09/2021

Actual:05/07/2021

Sources of funding

No external funding

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable